OptimizeRx Q1 2026 Earnings Preview
Source: SeekingAlpha
2026-05-11 17:35:44 ET
More on OptimizeRx
- OptimizeRx: Q4 Earnings Report Indicates Caution For 2026
- OptimizeRx Corporation (OPRX) Q4 2025 Earnings Call Transcript
- OptimizeRx signals $109M-$114M revenue target for 2026 as market shifts drive cautious outlook
- OptimizeRx Non-GAAP EPS of $0.51 beats by $0.29, revenue of $32.2M beats by $1.29M
- Seeking Alpha’s Quant Rating on OptimizeRx
Read the full article on Seeking Alpha
For further details see:
OptimizeRx Q1 2026 Earnings Preview
OptimizeRx Corporation
NASDAQ: OPRX
OPRX Trading
-1.49% G/L:
$6.505 Last:
187,736 Volume:
$6.66 Open:
OPRX Latest News
June 30, 2026 07:30:00 am
OptimizeRx Launches CopayCue(TM), a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent
June 25, 2026 07:30:00 am
OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms
June 11, 2026 02:48:23 pm
MissionIRNewsBreaks - OptimizeRx Corp. (NASDAQ: OPRX) Secures $35 Million Senior Credit Facility
$189,855,041
17,596,775
3.29%
31
N/A
Healthcare Providers & Services
Healthcare
US
Waltham
